Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 76 of the 79 references it cites were found in a registry or an index; 6 of the 32 sources its claims cite were checked for support.

The Flaws and Human Harms of Animal Experimentation

Open access
AKHTAR, AYSHA · 2015 · Cambridge Quarterly of Healthcare Ethics

Abstract

Nonhuman animal (“animal”) experimentation is typically defended by arguments that it is reliable, that animals provide sufficiently good models of human biology and diseases to yield relevant information, and that, consequently, its use provides major human health benefits. I demonstrate that a growing body of scientific literature critically assessing the validity of animal experimentation generally (and animal modeling specifically) raises important concerns about its reliability and predictive value for human outcomes and for understanding human physiology. The unreliability of animal experimentation across a wide range of areas undermines scientific arguments in favor of the practice. Additionally, I show how animal experimentation often significantly harms humans through misleading safety studies, potential abandonment of effective therapeutics, and direction of resources away from more effective testing methods. The resulting evidence suggests that the collective harms and costs to humans from animal experimentation outweigh potential benefits and that resources would be better invested in developing human-based testing methods.

Overview

CoChat Summary

## TL;DR

Aysha Akhtar argues that animal experimentation is broadly unreliable for predicting human outcomes because of laboratory effects, poor disease models, and species differences. She concludes that this unreliability causes significant human harms and that research resources should shift to human-based testing methods.

## Key findings

  • The paper states that more than 115 million animals are used worldwide annually in experimentation or to supply the biomedical industry.
  • In a cited 2007 systematic review, animal and clinical trial results for interventions in head injury, respiratory distress syndrome, osteoporosis, stroke, and hemorrhage matched only half of the time.
  • The paper reports that the FDA estimated in 2004 that 92% of drugs that pass preclinical tests, including animal tests, fail to reach the market; a later analysis suggested the failure rate is closer to 96%.
  • It gives multiple examples of translation failure, including more than 114 potential therapies for stroke that failed in human trials after animal testing, more than twenty drugs that failed in ALS trials, and all of about 90 HIV vaccines that succeeded in animals but failed in humans.

## Methods

  • This is a narrative argument/review drawing on a growing body of scientific literature on the validity of animal experimentation, including systematic reviews, comparative studies, and illustrative case examples.
  • The paper synthesizes evidence across several domains: laboratory environment effects, discordance between animal models and human diseases, and interspecies differences in physiology and genetics.
  • The main analysis is qualitative: it weighs reported translational failures and harms to argue that animal experimentation is poorly predictive of human outcomes.

## Limitations

  • The paper states that the efficacy of animal experimentation has been subjected to little systematic scrutiny and that much pharmaceutical preclinical data are proprietary and publicly unavailable, limiting precise counts of missed opportunities.
  • It acknowledges that some methodological problems in animal studies can be addressed by better standardization, but argues these efforts are insufficient; this is a limitation of the approach as discussed in the text, not a formal study limitation.
  • The text does not present a primary empirical study with a defined sample, so its conclusions depend on the scope and selection of cited literature; this is evident from the text.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1017/s0963180115000079

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

2 Valid · 5 Not valid · 26 Not checked · 21 Own results and interpretations

36 more claims · 1 with their cited sources checked

Create a free account to see all 54 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 13

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 79 references

Research works printed but not linked: 2

  1. Hart, 2009, Translational Neuroscience and Its Advancement of Animal Research Ethics, 71
  2. Woodroofe, 2007, ServiceNote: Human tissue research for drug discovery, Genetic Engineering and Biotechnology News, 27, 18

Cited by

See all 527

Metadata

Authors
AKHTAR, A.
Affiliations
University of Oxford (GB)
Corresponding author
AKHTAR, AYSHA
Venue
Cambridge Quarterly of Healthcare Ethics
Published
2015-09-14
Volume
24
Issue
4
Pages
407-419
ISSN
  • 0963-1801 (ISSN-L)
  • 1469-2147
OpenAlex
W2108829078
Cited by
527
References
79
Citations by year
2026: 58 · 2025: 69 · 2024: 101 · 2023: 72 · 2022: 55 · 2021: 37 · 2020: 44 · 2019: 39 · 2018: 22 · 2017: 13 · 2016: 13 · 2015: 3
FWCI
27.35
Type
journal article
Language
en
Open access
Locations
  • Cambridge Quarterly of Healthcare Ethics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • WBI Studies Repository (submittedVersion)
  • WBI Studies Repository (submittedVersion, cc-by)
  • Greater South Information System
Topics
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
  • Social Sciences › Law › Animal Law and Welfare
  • Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
Keywords
animal experimentation, animal models of human disease, predictive validity, animal welfare
MeSH terms
Animals, Animal Welfare, Disease Models, Animal, Drug Industry, Humans, Animal Rights, Toxicity Tests, Animal Experimentation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Flaws and Human Harms of Animal Experimentation. https://app.cochat.ai/papers/10.1017/s0963180115000079
The paper
AKHTAR, A. (2015). The Flaws and Human Harms of Animal Experimentation. Cambridge Quarterly of Healthcare Ethics. https://doi.org/10.1017/s0963180115000079

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.